文献速递脑血管病外科神经重症

立体定向放射外科治疗后残留脑动静脉畸形的管理

Management of Residual Brain Arteriovenous Malformations After Stereotactic Radiosurgery.
PubMed 文献 · World Neurosurg · 2018-06-01

该回顾性研究纳入87例立体定向放射外科治疗后3年存在残留脑动静脉畸形的患者,比较后续干预与保守治疗的结果。27例(31.0%)接受后续治疗,60例(69%)保守治疗;后续治疗完全治愈11例(40.7%),保守治疗残留畸形完全消退15例(25%)。作者认为首次照射后3-5年部分残留畸形可完全闭塞,再程SRS可能增加并发症风险,出血间隔风险下降支持保守管理。

要点

  • 87例残留BAVM患者中27例(31.0%)接受后续治疗,60例(69%)保守治疗。
  • 再程SRS后4例(14.8%)出现症状性并发症,7例(25.9%)出现无症状改变。
  • 后续治疗完全治愈11例(40.7%),保守治疗残留完全消退15例(25%)。

核心结论

  • 首次照射后3-5年相当数量残留BAVM可完全闭塞,再程SRS相关辐射剂量增加可能增加并发症风险。
  • SRS后(尤其破裂BAVM)出血间隔风险下降,进一步支持首次照射后3-5年残留BAVM的保守管理策略。

研究设计与样本

  • 回顾性纳入立体定向放射外科治疗后3年存在残留BAVM的患者。
  • 共87例,包括5例次全闭塞,平均随访33.7±36.6个月。
  • 比较干预与保守管理(观察)患者的人口学、血管构筑特征、并发症、出血及治愈率。
  • 分析保守治疗患者随访期间达到治愈或残留BAVM持续存在的特征。

主要发现

  • 27例(31.0%)接受后续治疗:放射外科23例、显微手术3例、栓塞1例;60例(69%)保守治疗。
  • 再程SRS后4例(14.8%)出现症状性并发症,7例(25.9%)出现无症状改变。
  • 3例(3.4%)随访期间出血,均初始表现为破裂BAVM。
  • 后续治疗完全治愈BAVM 11例(40.7%);保守治疗残留BAVM完全消退15例(25%)。

临床怎么用

  • 作者认为SRS后(尤其破裂BAVM)出血间隔风险下降支持对首次照射后3-5年残留BAVM采取保守管理。
  • 作者指出再程SRS相关辐射剂量增加可能增加并发症风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess outcome of residual brain arteriovenous malformation (BAVM) after stereotactic radiosurgery. METHODS: Patients with residual BAVM 3 years after radiosurgery were retrospectively included. Demographics, angioarchitectural characteristics, complications, bleeding, and cure rates of patients with intervention or conservative management (i.e., observation) were compared. We analyzed characteristics of patients treated conservatively who achieved cure or still had persistent BAVMs during follow-up. RESULTS: The study included 87 patients including 5 patients with subtotal obliteration with a mean follow-up time of 33.7 ± 36.6 months. Of patients, 27 (31.0%) received subsequent treatment (radiosurgery, n = 23; microsurgery, n = 3; embolization, n = 1), and 60 (69%) were treated conservatively. After repeat SRS, 4 (14.8%) patients experienced symptomatic complications after the second treatment, and 7 (25.9%) experienced asymptomatic changes. Three (3.4%) patients, all of whom presented initially with a ruptured BAVM, experienced hemorrhage during follow-up. Subsequent treatment was effective with a complete cure of BAVM in 11 patients (40.7%). Complete resolution of the residual BAVM occurred in 15 (25%) patients treated conservatively. CONCLUSIONS: Complete obliteration of a significant number of residual BAVMs may occur 3-5 years after the first irradiation, whereas increased radiation dose associated with repeat SRS may lead to an increased risk of complications. The fact that the interval risk of bleeding decreased after SRS (especially for ruptured BAVM) lends further strength to the argument for a conservative management approach for residual BAVM 3-5 years after the first irradiation.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Lenck S, Schwartz M, Hengwei J, et al. Management of Residual Brain Arteriovenous Malformations After Stereotactic Radiosurgery. World Neurosurg. 2018. PMID: 29864564. doi:10.1016/j.wneu.2018.05.180

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。